Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater

被引：0
|
作者：
Neoptolemos, J. P.
Moore, M. J.
Cox, T. F.
Valle, J. W.
Palmer, D. H.
Mcdonald, A.
Carter, R.
Tebbutt, N. C.
Dervenis, C.
Smith, D.
Glimelius, B.
Coxon, F. Y.
Lacaine, F.
Middleton, M. R.
Ghaneh, P.
Bassi, C.
Halloran, C.
Olah, A.
Rawcliffe, C. L.
Buechler, M. W.
机构：
[1] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
[2] Princess Margaret Hosp, Dept Med Oncol, Toronto, ON M4X 1K9, Canada
[3] Univ Toronto, Toronto, ON, Canada
[4] Christie NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England
[5] CRUK Inst Canc Studies, Birmingham, W Midlands, England
[6] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[7] Glasgow Royal Infirm, Glasgow G4 0SF, Lanark, Scotland
[8] Austin Hosp, Ludwig Oncol Unit, Heidelberg, Vic 3084, Australia
[9] Aiga Olga Hosp, Athens, Greece
[10] Clatterbridge Ctr Oncol NHS Fdn Trust, Wirral, Merseyside, England
[11] Akad Univ Hosp, Uppsala, Sweden
[12] Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, England
[13] Hosp Tenon, Paris, France
[14] Oxford Radcliffe Hosp, Oxford, England
[15] Univ Verona, Dept Surg, I-37100 Verona, Italy
[16] Petz Aladar Cty Hosp, Gyor, Hungary
[17] Heidelberg Univ, Heidelberg, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA4006
引用
收藏
页数：1
相关论文
共 50 条
  • [31] APACT: Phase III, Multicenter, International, Open-Label, Randomized Trial of Adjuvant nab-Paclitaxel Plus Gemcitabine (nab-P/G) Versus Gemcitabine (G) for Surgically Resected Pancreatic Adenocarcinoma
    Ko, A.
    Reni, M.
    Riess, H.
    Pelzer, U.
    O'Reilly, E. M.
    Winter, J.
    Oh, D. Y.
    Li, C. P.
    Tortora, G.
    Chang, H. M.
    Lopez, C. D.
    Tabernero, J.
    Van Cutsem, E.
    Philip, P.
    Goldstein, D.
    Berlin, J. D.
    Ferrara, S.
    Li, M.
    Lu, B.
    Romano, A.
    Marks, H.
    Biankin, A.
    Tempero, M. A.
    PANCREAS, 2019, 48 (10) : 1464 - 1464
  • [32] Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
    Neoptolemos, John P.
    Palmer, Daniel H.
    Ghaneh, Paula
    Psarelli, Eftychia E.
    Valle, Juan W.
    Halloran, Christopher M.
    Faluyi, Olusola
    O'Reilly, Derek A.
    Cunningham, David
    Wadsley, Jonathan
    Darby, Suzanne
    Meyer, Tim
    Gillmore, Roopinder
    Anthoney, Alan
    Lind, Pehr
    Glimelius, Bengt
    Falk, Stephen
    Izbicki, Jakob R.
    Middleton, Gary William
    Cummins, Sebastian
    Ross, Paul J.
    Wasan, Harpreet
    McDonald, Alec
    Crosby, Tom
    Ma, Yuk Ting
    Patel, Kinnari
    Sherriff, David
    Soomal, Rubin
    Borg, David
    Sothi, Sharmila
    Hammel, Pascal
    Hackert, Thilo
    Jackson, Richard
    Buechler, Markus W.
    LANCET, 2017, 389 (10073): : 1011 - 1024
  • [33] Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
    Cats, Annemieke
    Jansen, Edwin P. M.
    van Grieken, Nicole C. T.
    Sikorska, Karolina
    Lind, Pehr
    Nordsmark, Marianne
    Kranenbarg, Elma Meershoek-Klein
    Boot, Henk
    Trip, Anouk K.
    Swellengrebel, H. A. Maurits
    van Laarhoven, Hanneke W. M.
    Putter, Hein
    van Sandick, Johanna W.
    Henegouwen, Mark I. van Berge
    Hartgrink, Henk H.
    van Tinteren, Harm
    van de Velde, Cornelis J. H.
    Verheij, Marcel
    LANCET ONCOLOGY, 2018, 19 (05): : 616 - 628
  • [34] Mepitel Film for the Prevention of Acute Radiation Dermatitis in Breast Cancer: A Randomized Multicenter Open-Label Phase III Trial
    Behroozian, Tara
    Milton, Lauren
    Karam, Irene
    Zhang, Liying
    Ding, Keyue
    Lou, Julia
    Gallant, Francois
    Rakovitch, Eileen
    Tran, William
    Soliman, Hany
    Leung, Eric
    Vesprini, Danny
    Szumacher, Ewa
    Chen, Hanbo
    Donovan, Elysia
    Lam, Jacqueline
    Spadafora, Silvana
    Wronski, Matt
    Lavoie, Chris
    Walde, Natalie
    Lam, Emily
    Wong, Gina
    McKenzie, Erin
    Ariello, Krista
    Kennedy, Samantha
    Shariati, Saba
    Carothers, Katherine
    Gonzales, Glen
    Kagan, Yulya
    Chow, Edward
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (06) : 1250 - +
  • [35] Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial
    Iwase, Takuji
    Saji, Shigehira
    Iijima, Kotaro
    Higaki, Kenji
    Ohtani, Shoichiro
    Sato, Yasuyuki
    Hozumi, Yasuo
    Hasegawa, Yoshie
    Yanagita, Yasuhiro
    Takei, Hiroyuki
    Tanaka, Maki
    Masuoka, Hideji
    Tanabe, Masahiko
    Egawa, Chiyomi
    Komoike, Yoshifumi
    Nakamura, Toshitaka
    Ohtsu, Hiroshi
    Mukai, Hirofumi
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (18) : 3329 - +
  • [36] Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial
    Kerr, Rachel S.
    Love, Sharon
    Segelov, Eva
    Johnstone, Elaine
    Falcon, Beverly
    Hewett, Peter
    Weaver, Andrew
    Church, David
    Scudder, Claire
    Pearson, Sarah
    Julier, Patrick
    Pezzella, Francesco
    Tomlinson, Ian
    Domingo, Enric
    Kerr, David J.
    LANCET ONCOLOGY, 2016, 17 (11): : 1543 - 1557
  • [37] CONKO-001: FINAL RESULTS OF THE RANDOMIZED, PROSPECTIVE, MULTICENTER PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY WITH GEMCITABINE VERSUS OBSERVATION IN PATIENTS WITH RESECTED PANCREATIC CANCER (PC)
    Riess, H.
    Neuhaus, P.
    Post, S.
    Gellert, K.
    Ridwelski, K.
    Schramm, H.
    Zuelke, C.
    Fahlke, J.
    Langrehr, J.
    Oettle, H.
    ANNALS OF ONCOLOGY, 2008, 19 : 45 - 46
  • [38] CONKO-001: Final results of the randomized, prospective, multicenter phase III trial of adjuvant chemotherapy with gemcitabine versus observation in patients with resected pancreatic cancer (PC)
    Neuhaus, P.
    Riess, H.
    Post, S.
    Gellert, K.
    Ridwelski, K.
    Schramm, H.
    Zuelke, C.
    Fahlke, J.
    Langrehr, J.
    Oettle, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [39] En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial
    D'Andrea, David
    Soria, Francesco
    Hurle, Rodolfo
    Enikeev, Dmitry
    Kotov, Sergey
    Regnier, Sophie
    Xylinas, Evanguelos
    Lusuardi, Lukas
    Heidenreich, Axel
    Cai, Chao
    Frego, Nicola
    Taraktin, Mark
    Ryabov, Maxim
    Gontero, Paolo
    Comperat, Eva
    Shariat, Shahrokh F.
    EUROPEAN UROLOGY ONCOLOGY, 2023, 6 (05): : 508 - 515
  • [40] Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial
    Mileshkin, Linda R.
    Moore, Kathleen N.
    Barnes, Elizabeth H.
    Gebski, Val
    Narayan, Kailash
    King, Madeleine
    Bradshaw, Nathan
    Lee, Yeh Chen
    Diamante, Katrina
    Fyles, Anthony W.
    Small, William, Jr.
    Gaffney, David K.
    Khaw, Pearly
    Brooks, Susan
    Thompson, J. Spencer
    Huh, Warner K.
    Mathews, Cara A.
    Buck, Martin
    Suder, Aneta
    Lad, Thomas E.
    Barani, Igor J.
    Holschneider, Christine H.
    Van Dyk, Sylvia
    Quinn, Michael
    Rischin, Danny
    Monk, Bradley J.
    Stockler, Martin R.
    LANCET ONCOLOGY, 2023, 24 (05): : 468 - 482
12345